Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/20/2003US20030215869 Use of azetidinone compounds
11/20/2003US20030215866 Models of genetic interactions and methods of use
11/20/2003US20030215865 Preparing biosensor which monitors target-receptor binding activity via production of electrically detected signals upon adjustment in cantilever mass or static deflection
11/20/2003US20030215864 Improved DNA hybridization/conjugation
11/20/2003US20030215854 Identifying transcription factors for use in modulation of gene expression; high-throughput assay
11/20/2003US20030215849 PDPK1s as modifiers of the p53 pathway and methods of use
11/20/2003US20030215847 Comprises nucleotide sequences coding polypeptides for use in diagnosis, prevention and treatment of bone disorders; tissue engineering
11/20/2003US20030215846 Methods of constructing and screening diverse expression libraries
11/20/2003US20030215841 Using fluorescent microscopy to concurrently monitor gene expression/transcription from a multiplicity of genes; diagnosing cancer and viral diseases
11/20/2003US20030215840 Identifying compounds capable of treating atherosclerosis, reperfusion injury, hypertension, restenosis, arterial inflammation, heart failure, thrombosis and endothelial cell disorders
11/20/2003US20030215836 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
11/20/2003US20030215834 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program
11/20/2003US20030215830 Using polymerase chain reaction to identify and measure messenger RNA present in sample
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215828 Gene markers for lung cancer
11/20/2003US20030215826 Labeled oligonucleotides for use as diagnostic tools in nucleic acid replication
11/20/2003US20030215825 Method of detecting molecular target by particulate binding
11/20/2003US20030215823 Uses of galanin GALR2 receptors
11/20/2003US20030215822 Comprises nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological and developmental disorder
11/20/2003US20030215819 Compositions and methods for inferring a response to statin
11/20/2003US20030215816 Method for sequencing nucleic acids by observing the uptake of nucleotides modified with bulky groups
11/20/2003US20030215813 Isolated nucleic acid encoding a polypeptide of given amino acid sequence; expression vectors; identification of modulators useful for the treatment of mental/brain disorders
11/20/2003US20030215810 Simple catalytic DNA biosensors for ions based on color changes
11/20/2003US20030215808 Selecting, screening or characterizing a compound by contacting it with lymphocytes and determing it ability to regulate activity
11/20/2003US20030215805 Novel genes, compositions, kits, and methods for identification, assessment prevention, and therapy of breast cancer
11/20/2003US20030215804 Novel mechanism for identifying drugs for the treatment of type II diabetes
11/20/2003US20030215796 Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
11/20/2003US20030215793 Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
11/20/2003US20030215792 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least on neuropeptide
11/20/2003US20030215791 Method of and system for multiplexed analysis by spectral imaging
11/20/2003US20030215787 Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states
11/20/2003US20030215511 Dissolving Protein or mixtures of different proteins, metal salt, acid, base or mixture to adjust the pH value in the water, degassing the protein mixtures, extruding, spinning or casting the protein into a matrix and heat treating
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215453 Provides a method of killing or inhibiting that growth of cancer cells that express the VpreB1 protein; treatment of B-cell lymphoma, T-cell lymphoma, T-cell leukemia, and non-Hodgkin's lymphoma
11/20/2003US20030215452 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/20/2003US20030215451 In treatment (including prevention) or identification of a human subject at risk of tissue damage, preferably liver or heart tissue damage
11/20/2003US20030215447 Produced by hybridoma cell line DSM ACC 2533
11/20/2003US20030215446 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays
11/20/2003US20030215445 Concerns an 88 kDa glycoprotein growth factor ("GP88" or "PCDGF") and compositions and methods which affect the expression and biological activity of GP88; useful for diagnosis and treatment of diseases
11/20/2003US20030215444 And stimulate erythropoiesis; teatment of anemia
11/20/2003US20030215440 Antithrombotic thrombin variants
11/20/2003US20030215438 Enzyme treatment of foodstuffs for celiac sprue
11/20/2003US20030215428 Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
11/20/2003US20030215420 Novel therapeutic treatment of chronic obstructive pulmonary disease
11/20/2003US20030215402 Porphyromonas gingivalis recombinant proteins and truncations
11/20/2003US20030215389 Methods for detecting vasculopathies and tumors
11/20/2003US20030215359 Tests for the rapid evaluation of ischemic states and kits
11/20/2003US20030215358 Has adhesive properties and can be used to make a multi-layered test strip or the composition can be used in the sample wells of microfluidic devices.
11/20/2003US20030214655 Reflectometer
11/20/2003US20030214652 Process and apparatus for qualitative and quantitative analysis of an analyte
11/20/2003US20030214394 Method and apparatus for sensing tire performance and wear
11/20/2003US20030214311 Method for measuring skin surface hydration and device for applying the method
11/20/2003US20030213746 Detecting oxidative stress-mediated dehydroepiandrosterone in a test sample, diagnosing neuropathologic disorder; a testing kits
11/20/2003US20030213315 Selective profiling of bulk building material for characterization using a concrete contamination profiling technology
11/20/2003US20030213312 Serum transfer cup
11/20/2003US20030213292 Method for determining engine oil contamination
11/20/2003US20030213290 Systems and methods for determining the absorption and specific gravity properties of compacted and loose material including fine and coarse aggregates
11/20/2003DE20314395U1 Test strip for determining urea or glucose content in body fluids, comprising substrate with pointed projection on one side, central layer with aperture forming sample chamber and cover strip with second point forming inlet
11/20/2003CA2775017A1 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
11/20/2003CA2736605A1 System for measuring material properties from a moving construction vehicle
11/20/2003CA2524404A1 Sample collection device comprising a hydrophilic membrane for separating particulate material in the sample
11/20/2003CA2492044A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003CA2487947A1 Polyelectrolyte complex (e.g.zwitterionic polythiophenes) with a receptor (e.g. polynucleotide, antibody etc.) for biosensor applications
11/20/2003CA2487236A1 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells
11/20/2003CA2485609A1 Fluid tester
11/20/2003CA2485602A1 System and methods for rapid and automated screening of cells
11/20/2003CA2485563A1 Solid-phase assisted spectroscopic and spectrometric analysis of complex mixtures of biopolymers
11/20/2003CA2485459A1 Continuous on-line process control of residua distillation
11/20/2003CA2485437A1 Peptide compounds and their use as protease substrates
11/20/2003CA2485373A1 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003CA2484897A1 Soluble st2 as a cardiovascular disease marker and therapeutic target
11/20/2003CA2484845A1 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
11/20/2003CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003CA2484743A1 Quality assays for antigen presenting cells
11/20/2003CA2484732A1 A method to rapidly prepare and screen formulations and compositions containing same
11/20/2003CA2484669A1 Brachyspira hyodysenteriae vaccine
11/20/2003CA2484628A1 Collection assembly
11/20/2003CA2484549A1 Liver inflammation predictive genes
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003CA2482689A1 Simple catalytic dna biosensors for ions based on color changes
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003CA2451081A1 Adenosine a<sb>3</sb> receptor modulators
11/20/2003CA2428740A1 Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid (csf)
11/19/2003EP1363245A1 Three-dimensional verification supporting apparatus, three-dimensional structure verification method, record medium, and program
11/19/2003EP1363129A1 Control or standard in coagulation tests
11/19/2003EP1363128A2 Diagnosis of myocardial infarction and acute coronary syndrom by combination of markers
11/19/2003EP1363127A2 Multiparameter facs assays to detect alterations in cellular parameters
11/19/2003EP1363126A1 Multidimensional leukocyte differential analysis
11/19/2003EP1363124A1 Method for detecting an analyte with an elasto-optical biosensor
11/19/2003EP1363123A2 Method for predicting engine oil contamination
11/19/2003EP1363120A1 Tool for making a sample holder
11/19/2003EP1362925A1 Compositions for assaying glycoprotein
11/19/2003EP1362922A1 Electrochemical sensor
11/19/2003EP1362913A2 Interaction trap system for isolating proteins
11/19/2003EP1362868A2 Humanized and chimeric monoclonal antibodies that bind epidermal growth factor receptor (EGF-R)
11/19/2003EP1362827A1 Method of fabrication of a microfluidic device
11/19/2003EP1362801A2 Test strip containers and methods of using the same
11/19/2003EP1362788A2 Devices, systems and methods for the containing and use of liquid solutions
11/19/2003EP1362601A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
11/19/2003EP1362551A1 Minimal procedure analyte test system
1 ... 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 ... 3937